Cholesterol

Cholesterol

Novel Atherogenic Indices Linked to Higher Risk for Metabolic Syndrome and Fatty Liver Disease

Researchers from the Alborz University of Medical Sciences in Karaj, Iran, have conducted a systematic review and meta-analysis of 34 studies to evaluate the association between novel atherogenic indices and the pathophysiology of metabolic dysfunction-associated steatotic liver disease (MASLD). The study found that non-high-density lipoprotein cholesterol (non-HDL-C) and non-HDL-C/HDL-C

Cholesterol

Novel Atherogenic Indices Linked to Higher Risk for Metabolic Syndrome and Fatty Liver Disease

Researchers from the Alborz University of Medical Sciences in Karaj, Iran, have conducted a systematic review and meta-analysis of 34 studies to evaluate the association between novel atherogenic indices and the pathophysiology of metabolic dysfunction-associated steatotic liver disease (MASLD). The study found that non-high-density lipoprotein cholesterol (non-HDL-C) and non-HDL-C/HDL-C